Engineered virus-like particles (eVLPs) are emerging as a distinct delivery platform for CRISPR-Cas ribonucleoprotein (RNP) complexes, combining the...

Spatial Perturb-seq enables pooled in vivo CRISPR screening with single-cell, whole-transcriptome readouts preserved within intact tissue...

A study published last week in Cell Stem Cell demonstrates for the first time that a topical, lipid nanoparticle-based gene editing approach can...

Some of the best links we picked up around the internet

nChroma Bio has received regulatory clearance in Hong Kong to initiate a Phase 1/2 clinical trial of its lead candidate CRMA-1001, marking the first...

Regeneron Pharmaceuticals and Tessera Therapeutics have formed a global partnership to develop and commercialise TSRA-196, Tessera’s lead in vivo Gene...

Researchers at the Gene Editing Institute, ChristianaCare Health System, have used CRISPR to selectively knock down a cancer-specific version of the...

Caribou Biosciences reported last week that its off-the-shelf, CRISPR-edited anti-CD19 CAR-T, vispa-cel (formerly CB-010), achieved response rates and...